Regeneron presents real-world data on EYLEA HD's effectiveness and economic benefits in treating retinal diseases at ARVO 2025. Regeneron Pharmaceuticals announced the upcoming presentation of data on ...
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced the presentation of 27 abstracts, including eight oral sessions, featuring EYLEA HD (aflibercept) Injection 8 mg at the upcoming ARVO 2025 ...
Forbes contributors publish independent expert analyses and insights. John Hall covers entrepreneurial topics that help companies grow. Nearly everyone in an organization feels the pressure to act ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results